Nirogacestat May Offer Hope to People with Desmoid Tumors - Cancer Currents Blog

National Cancer Institute sent this bulletin at 05/03/2023 10:48 AM EDT

Having trouble viewing this email? View it as a Web page.

Nirogacestat May Offer Hope to People with Desmoid Tumors
05/01/2023
	In a clinical trial, the drug nirogacestat shrank tumors in 40% of people with desmoid tumors. Treatment with nirogacestat also substantially improved progression-free survival, pain, and physical functioning, compared with patients treated with a placebo.

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.